Natalie Raphael was diagnosed as having glucokinase MODY at the end of her first pregnancy. In her second pregnancy she had a recently introduced blood test that showed her fetus had not inherited her change in the glucokinase gene so was at risk of growing large. As a result of this she was given long-acting insulin to lower her glucose. Alice Hughes is the researcher who did the key study that proved the new blood test was both practical and accurate in glucokinase pregnancy.
Podden och tillhörande omslagsbild på den här sidan tillhör Andrew Hattersley and Maggie Shepherd. Innehållet i podden är skapat av Andrew Hattersley and Maggie Shepherd och inte av, eller tillsammans med, Poddtoppen.